pyridoxine tirzepatide with B6 for weight loss with minimal side effects telehealth services compounded tirzepatide injections

EMA EPAR Wegovy (European Public Assessment Report & SmPC) Prescribing Information Wegovy (semaglutide 2.4 mg) Novo Nordisk NEJM (2021) STEP 1: Semaglutide 2.4 mg in Adults with Overweight/Obesity NEJM (2022) Semaglutide in Adolescents with Obesity (STEP TEENS) Wegovy (semaglutide) Indications & HCP Information | novoMEDLINK

Those with better blood sugar metabolism lose less weight

Weight loss accelerates as doses increase

The jump from 5 mg to 7.5 mg frequently causes more nausea than earlier increases

If hypoglycaemia is suspected, work with your diabetes team to optimise your medication regimen and meal timing

B12 shots are usually safe for most people